Market Cap: $182.43M
WI
Whitehawk Therapeutics Inc
WHWK
NASDAQ (NASDAQ Global Market)USD
Market Cap: $182.43M
Whitehawk Therapeutics Showcases Breakthroughs in Antibody-Drug Conjugate Development at AACR Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics firm, confirms its participation in t…
Whitehawk Therapeutics Advances Oncology Research with Upcoming AACR Presentations Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company, is poised to make significant contribut…
Whitehawk Therapeutics Advances Antibody-Drug Conjugate Programs for Cancer Treatment Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company, makes significant strides in its ant…
Whitehawk Therapeutics Strengthens Leadership with Appointment of Dr. Margaret Dugan as CMO Whitehawk Therapeutics, Inc. makes a significant stride in its oncology therapeutic development by appointin…
Whitehawk Therapeutics Welcomes Dr. Margaret Dugan as Chief Medical Officer Whitehawk Therapeutics, Inc., an innovative player in the oncology therapeutics space, appoints Dr. Margaret Dugan as its Ch…
Whitehawk Therapeutics Unveils Promising Findings on PTK7 as a Cancer Target At the recent 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Whitehawk Therapeu…
Whitehawk Therapeutics Advances PTK7 Research at Major Oncology Conference Whitehawk Therapeutics, Inc., an innovative player in the oncology therapeutics landscape, recently showcases significant fin…
Whitehawk Therapeutics Advances Cancer Treatment with Promising PTK7 Findings Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an innovative oncology therapeutics company, has made significant strides in…
Whitehawk Therapeutics Partners with Tempus AI to Enhance Therapeutic Development Whitehawk Therapeutics Inc. announces a significant multi-year collaboration with Tempus AI, aiming to bolster its the…
Whitehawk Therapeutics Embarks on Strategic Oncology Partnership with Tempus AI Whitehawk Therapeutics, Inc. is taking a significant step forward in its oncology pipeline by announcing a multi-year co…
### Whitehawk Therapeutics and Tempus AI: A Strategic Alliance in Oncology Whitehawk Therapeutics, Inc. announces a significant multi-year collaboration with Tempus AI Inc., aimed at enhancing its onc…